Published in Am J Med on April 01, 1980
Fibronectins: multifunctional modular glycoproteins. J Cell Biol (1982) 8.05
Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci U S A (1981) 2.34
Isolation of a fibronectin-binding protein from Staphylococcus aureus. Infect Immun (1982) 2.02
Human fibronectin binding to staphylococcal surface protein and its relative inefficiency in promoting phagocytosis by human polymorphonuclear leukocytes, monocytes, and alveolar macrophages. Infect Immun (1981) 1.97
Deposition of plasma fibronectin in tissues. Proc Natl Acad Sci U S A (1981) 1.68
Opsonizing and bactericidal effects of normal human serum on nontypable Haemophilus influenzae. Infect Immun (1983) 1.62
Clinical significance of translocation. Gut (1994) 1.44
Fibronectin in blood products--an in vitro and in vivo study. J Clin Pathol (1983) 1.42
Opsonic glycoprotein (plasma fibronectin) levels after burn injury. Relationship to extent of burn and development of sepsis. Ann Surg (1980) 1.37
Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease. J Clin Invest (1982) 1.31
Fibronectin binds to the C1q component of complement. Proc Natl Acad Sci U S A (1982) 1.30
Fibronectin-mediated binding and phagocytosis of polystyrene latex beads by baby hamster kidney cells. J Cell Biol (1983) 1.22
Interactions of fibronectin with Treponema pallidum. Genitourin Med (1985) 1.19
The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin. Clin Exp Immunol (1983) 1.13
Mechanism of acute depletion of plasma fibronectin following thermal injury in rats. Appearance of a gelatinlike ligand in plasma. J Clin Invest (1984) 1.07
Role of fibronectin in human monocyte and macrophage bactericidal activity. Infect Immun (1985) 1.05
Fibronectin and immune complexes in rheumatic diseases. Ann Rheum Dis (1987) 1.03
Fibronectin and cell shape in vivo: studies on the endometrium during pregnancy. J Cell Biol (1982) 0.96
Fibronectin binding to complement subcomponent C1q. Localization of their respective binding sites. Biochem J (1985) 0.96
Stimulation of human monocyte/macrophage-derived growth factor (MDGF) production by plasma fibronectin. Am J Pathol (1983) 0.95
Opsonic fibronectin deficiency and sepsis. Cause or effect? Ann Surg (1982) 0.94
Plasma fibronectin and associated variables in surgical intensive care patients. Ann Surg (1983) 0.93
Susceptibility of congenitally athymic (nude) mice to sporotrichosis. Infect Immun (1983) 0.92
Comparison of intravenous gamma globulin and a monoclonal anti-Fc receptor antibody as inhibitors of immune clearance in vivo in mice. J Clin Invest (1986) 0.92
Essential charged amino acids in the binding of fibronectin to gelatin. Biochem J (1982) 0.91
Reversal of fibronectin and opsonic deficiency in patients. A controlled study. Ann Surg (1984) 0.89
Association of fibronectin with carboxy-group-modified proteins in vitro. Biochem J (1982) 0.88
Effect of administration of fibronectin or aprotinin on liver regeneration after experimental hepatectomy. Ann Surg (1990) 0.87
Diagnosing malnutrition. Gut (1986) 0.86
An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan. Infect Immun (1993) 0.85
Plasma fibronectin in Crohn's disease. Gut (1989) 0.85
Fibronectin levels during intraperitoneal inflammation. Infect Immun (1983) 0.84
Protective effects of a leukotriene inhibitor and a leukotriene antagonist on endotoxin-induced mortality in carrageenan-pretreated mice. Infect Immun (1992) 0.84
Cryoprecipitogogue from normal serum: mechanism for cryoprecipitation of immune complexes. Proc Natl Acad Sci U S A (1981) 0.84
Studies on fibronectin in inflammatory vs non-inflammatory polymorphonuclear leucocytes of patients with rheumatoid arthritis. II. Synthesis and release of fibronectin in vitro. Clin Exp Immunol (1985) 0.83
Lung vascular permeability after reversal of fibronectin deficiency in septic sheep. Correlation with patient studies. Ann Surg (1983) 0.82
Plasma fibronectin synthesis in normal and injured humans as determined by stable isotope incorporation. J Clin Invest (1989) 0.82
Studies on fibronectin in inflammatory vs non-inflammatory polymorphonuclear leucocytes of patients with rheumatoid arthritis. I. Immunofluorescent and flow cytometric analysis. Clin Exp Immunol (1985) 0.82
Fibronectin binds to C1q: possible mechanisms for their co-precipitation in cryoglobulins from patients with systemic lupus erythematosus. Clin Exp Immunol (1983) 0.82
An experimental model for the study of the opsonic activity of fibronectin in the clearance of intravascular complexes. Br J Exp Pathol (1984) 0.81
Gram-positive bacteria-induced granulocytopenia and pulmonary leukostasis in rabbits. Infect Immun (1982) 0.80
Circulating immunoreactive and bioassayable opsonic plasma fibronectin during experimental tumour growth. Br J Cancer (1980) 0.79
The effect of fibronectin-coated implant on canine osseointegration. J Periodontal Implant Sci (2011) 0.78
Fibronectin in fulminant hepatic failure. Br Med J (Clin Res Ed) (1982) 0.77
Perspectives for the future. Intensive Care Med (1993) 0.77
Quantification of tissue fibronectin from terminal villi of placenta. Biochem J (1985) 0.76
Plasma fibronectin and thyroid function. J Clin Pathol (1985) 0.76
Changes in plasma fibronectin during allogeneic bone marrow transplantation. J Clin Pathol (1985) 0.75
Opsonic requirements for hepatic clearance of pneumococci. Infect Immun (1986) 0.75
Identification of fibronectin fragments that bind to carboxy-group-modified proteins. Biochem J (1983) 0.75
Fibronectin in chronic inflammation: studies using the rat air pouch model of chronic allergic inflammation. Br J Exp Pathol (1985) 0.75
Disseminated intravascular coagulation (DIC) induced by liquoid (polyanetholsulfonate) in the rat. V. Effects on circulating fibronectin. Br J Exp Pathol (1986) 0.75
Lung vascular injury with protease infusion. Relationship to plasma fibronectin. Ann Surg (1985) 0.75
The adult respiratory distress syndrome. Yale J Biol Med (1987) 0.75
Comparative influence of blood-borne nonbacterial particles and Staphylococcus aureus on fibronectin, complement and immunoglobulin. Ann Surg (1982) 0.75
Involvement of the bcl-2 gene in human follicular lymphoma. Science (1985) 8.19
The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science (1985) 6.63
Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature (1985) 2.91
Physiology and physiopathology of the reticuloendothelial system. Arch Intern Med (1970) 2.72
Biochemical and immunological characterization of human opsonic alpha2SB glycoprotein: its identity with cold-insoluble globulin. J Biol Chem (1978) 2.05
Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol (1996) 2.05
Physiologic role of cold-insoluble globulin in systemic host defense: implications of its characterization as the opsonic alpha 2-surface-binding glycoprotein. Ann N Y Acad Sci (1978) 1.86
DNA rearrangements in human follicular lymphoma can involve the 5' or the 3' region of the bcl-2 gene. Proc Natl Acad Sci U S A (1987) 1.74
Cryoprecipitate reversal of opsonic alpha2-surface binding glycoprotein deficiency in septic surgical and trauma patients. Science (1978) 1.73
Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol (1998) 1.71
Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N Engl J Med (1983) 1.58
Reference sample method for cardiac output and regional blood flow determinations in the rat. J Appl Physiol (1976) 1.52
Opsonic alpha2 surface binding glycoprotein therapy during sepsis. Ann Surg (1978) 1.49
Fibronectin as a co-factor necessary for optimal granulocyte phagocytosis of Staphylococcus aureus. J Reticuloendothel Soc (1981) 1.45
Evaluation of a rapid immunoturbidimetric assay for opsonic fibronectin in surgical and trauma patients. J Lab Clin Med (1981) 1.44
Method for collection and determination of 14CO-2 for in vitro metabolic studies. J Lipid Res (1966) 1.44
Reticuloendothelial blockade and recovery as a function of opsonic activity. Am J Physiol (1969) 1.42
Opsonic glycoprotein (plasma fibronectin) levels after burn injury. Relationship to extent of burn and development of sepsis. Ann Surg (1980) 1.37
Anuria and acute tubular necrosis associated with gentamicin and cephalothin. JAMA (1972) 1.36
Dental defects associated with neonatal symptomatic hypocalcaemia. Arch Dis Child (1973) 1.35
Tetradecanoyl phorbol acetate stimulates latent collagenase production by cultured human endothelial cells. Cell (1980) 1.35
Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis. Am J Surg Pathol (1994) 1.27
Purification of alpha-2-opsonic protein from human serum and its measurement by immunoassay. J Reticuloendothel Soc (1978) 1.26
Association of the human type C retrovirus with a subset of adult T-cell cancers. Cancer Res (1983) 1.25
Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidence. J Natl Cancer Inst (1995) 1.19
Effect of surgical trauma on the clearance and localization of blood-borne particulate matter. Surgery (1972) 1.18
Isolation and biochemical characterization of alpha-2-opsonic glycoprotein from rat serum. J Biol Chem (1977) 1.16
Humoral deficiency and reticuloendothelial depression after traumatic shock. Am J Physiol (1976) 1.16
Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers. J Natl Cancer Inst (1980) 1.15
Humoral recognition deficiency in the etiology of reticuloendothelial depression induced by surgery. Ann Surg (1973) 1.14
Central nervous system complications of non-Hodgkin's lymphoma. The potential role for prophylactic therapy. Am J Med (1979) 1.13
Hepatocyte injury during post-operative sepsis: activated neutrophils as potential mediators. J Leukoc Biol (1988) 1.13
Normal fibronectin levels as a function of age in the pediatric population. Pediatr Res (1983) 1.11
Cardiovascular hemodynamics after opsonic alpha-2-surface binding glycoprotein therapy in injured patients. Surgery (1979) 1.08
Mechanism of acute depletion of plasma fibronectin following thermal injury in rats. Appearance of a gelatinlike ligand in plasma. J Clin Invest (1984) 1.07
Decreased resistance to intravenous tumour-cell challenge during reticuloendothelial depression following surgery. Br J Cancer (1976) 1.06
Involvement of the opsonic system in starvation induced depression of the reticuloendothelial system. Proc Soc Exp Biol Med (1968) 1.06
Comparative disappearance and localization of isotopically labeled opsonic protein and soluble albumin following surgical trauma. J Reticuloendothel Soc (1976) 1.05
Purification and biochemical characterization of a macrophage stimulating alpha-2-globulin opsonic protein. J Reticuloendothel Soc (1976) 1.04
SEROLOGICAL STUDIES ON SUGAR : I. REACTIONS BETWEEN SOLUTIONS OF REAGENT SUCROSE AND TYPE II ANTIPNEUMOCOCCUS SERUM. J Exp Med (1939) 1.04
The biology of tumor growth in the non-Hodgkin's lymphomas. A dual parameter flow cytometry study of 220 cases. J Clin Invest (1984) 1.03
Isolation, purification and characterization of opsonic protein. J Reticuloendothel Soc (1973) 1.03
Prevention of liver reticuloendothelial systemic host defense failure after surgery by intravenous opsonic glycoprotein therapy. Ann Surg (1978) 1.02
Deficits in reticuloendothelial humoral control mechanisms in patients after trauma. J Trauma (1976) 0.97
Influence of gelatin on bioassayable and immunoreactive opsonic fibronectin. Proc Soc Exp Biol Med (1981) 0.97
Opsonic fibronectin after trauma and particle injection determined by a peritoneal macrophage monolayer assay. J Reticuloendothel Soc (1981) 0.97
CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood (1995) 0.97
Reticuloendothelial systemic response to operative trauma as influenced by cryoprecipitate or cold-insoluble globulin therapy. J Reticuloendothel Soc (1979) 0.96
Disturbances in circulating opsonic activity in man after operative and blunt trauma. J Surg Res (1977) 0.96
Increased recycling of (alpha)5(beta)1 integrins by lung endothelial cells in response to tumor necrosis factor. J Cell Sci (2000) 0.95
Humoral mediated macrophage response during tumour growth. Br J Cancer (1975) 0.95
Dynamics of insulin secretion and resistance after burns. J Trauma (1977) 0.94
Opsonic fibronectin deficiency and sepsis. Cause or effect? Ann Surg (1982) 0.94
Vascular clearance and metabolism of lipid by the reticuloendothelial system in dogs. Am J Physiol (1971) 0.94
Hypercalcemia associated with T-cell lymphoma-leukemia. Am J Clin Pathol (1981) 0.93
Characterization and source of a renin-like enzyme in anephric humans. J Clin Endocrinol Metab (1968) 0.93
Kinetics of endogenously labeled plasma fibronectin: incorporation into tissues. Am J Physiol (1983) 0.92
Low-grade intravascular coagulation and reticuloendothelial function. Am J Physiol (1978) 0.91
An affinity method for the rapid purification of opsonic alpha 2 SB glycoprotein from serum. Adv Shock Res (1979) 0.91
Synthesis of actin by cultured guinea pig megakaryocytes. Complex formation with fibrin. Biochim Biophys Acta (1978) 0.90
Surgical stess and reticuloendothelial function. Surgery (1969) 0.90
Bioassay of serum opsonin and its depletion after colloid clearance in dogs. Am J Physiol (1972) 0.90
Fibronectin fragments released from phorbol ester-stimulated pulmonary artery endothelial cell monolayers promote neutrophil chemotaxis. Immunology (1991) 0.90
Von Willebrand factor (VIII R:Ag), fibronectin, and insulin-like growth factors I and II in diabetic retinopathy and nephropathy. Diabetes (1984) 0.89
Regression and clonally distinct recurrence of human immunodeficiency virus related Burkitt-like lymphoma during antiretroviral therapy. Leuk Lymphoma (2001) 0.89
Electroimmunoassay of alpha-2-opsonic protein during reticuloendothelial blockade. Am J Physiol (1977) 0.89
Reversal of fibronectin and opsonic deficiency in patients. A controlled study. Ann Surg (1984) 0.89
Effect of endotoxin on fibronectin and Kupffer cell activity. Hepatology (1985) 0.88
Mechanism mediating reticuloendothelial system depression after surgery. Proc Soc Exp Biol Med (1970) 0.88
Kupffer cell phagocytosis and metabolism of a variety of particles as a function of opsonization. J Reticuloendothel Soc (1965) 0.88
Reversal of opsonic deficiency in surgical, trauma, and burn patients by infusion of purified human plasma fibronectin. Correlation with experimental observations. Am J Med (1986) 0.88
Cheek cell phospholipids in human infants: a marker of docosahexaenoic and arachidonic acids in the diet, plasma, and red blood cells. Am J Clin Nutr (2000) 0.88
Evaluation of the mechanism of glucan-induced stimulation of the reticuloendothelial system. J Reticuloendothel Soc (1970) 0.88
Influence of opsonic fibronectin deficiency on lung fluid balance during bacterial sepsis. J Appl Physiol Respir Environ Exerc Physiol (1980) 0.88
Inhibition of phagocytosis and glucose metabolism of alveolar macrophages during pulmonary tumour growth. Br J Cancer (1977) 0.87
Prolonged initial remission in patients with nodular mixed lymphoma. Ann Intern Med (1984) 0.87
Opsonin levels in reticuloendothelial regulation during and following pregnancy. J Reticuloendothel Soc (1973) 0.86
A radial immunodiffusion method for the measurement of rat fibrinogen and fibrin degradation products. Vox Sang (1979) 0.86
Fibronectin attenuates increased endothelial monolayer permeability after RGD peptide, anti-alpha 5 beta 1, or TNF-alpha exposure. Am J Physiol (1995) 0.86
Reticuloendothelial phagocytic response to bacterial challenge after traumatic shock. Circ Shock (1977) 0.86
Neutrophil-mediated lung localization of bacteria: a mechanism for pulmonary injury. Surgery (1981) 0.86
Extracellular matrix incorporation of normal and NEM-alkylated fibronectin: liver and spleen deposition. Am J Physiol (1995) 0.86
Phagocytosis of gelatinized "R. E. test lipid emulsion" by Kupffer cells: electronmicroscopic observations. Exp Mol Pathol (1976) 0.85
Rebound elevation of fibronectin after tissue injury and ischemia: role of fibronectin synthesis. Am J Physiol (1992) 0.85
Fibronectin levels during intraperitoneal inflammation. Infect Immun (1983) 0.84
Effect of surgical trauma on host defense. Surg Annu (1975) 0.84
Opsonic fibronectin deficiency in the etiology of starvation-induced reticuloendothelial phagocytic dysfunction. Exp Mol Pathol (1982) 0.84
Effect of x-irradiation on reticuloendothelial phagocytic function and serum opsonic activity. Am J Physiol (1969) 0.84
Generation of neutrophil chemotactic activity by phorbol ester-stimulated calf pulmonary artery endothelial cells. J Leukoc Biol (1988) 0.84
Amyloid AA protein. Cellular distribution and appearance. Am J Clin Pathol (1977) 0.84
Correction of serum opsonic defects after burn and sepsis by opsonic fibronectin administration. Arch Surg (1983) 0.84
Immunoreactive serum opsonic alpha 2 sb glycoprotein as a noninvasive index of RES systemic defense after trauma. Adv Shock Res (1979) 0.84
Blood-borne collagenous debris complexes with plasma fibronectin after thermal injury. Blood (1990) 0.83
Serum calcium and hepatic Kupffer cell phagocytosis. Proc Soc Exp Biol Med (1975) 0.83
Increased creatinine clearance following cryoprecipitate infusion in trauma and surgical patients with decreased renal function. J Trauma (1980) 0.82
Metastatic melanoma of the gallbladder. Am J Roentgenol Radium Ther Nucl Med (1972) 0.82
Opsonin depletion after surgery. Nature (1970) 0.82
Plasma fibronectin synthesis in normal and injured humans as determined by stable isotope incorporation. J Clin Invest (1989) 0.82